CpG immunostimulatory sequences enhance contact hypersensitivity responses in mice

Journal of Investigative Dermatology

Volumn 123, Issue 3, 2004, Pages 488-493

  Akiba, Hitoshi ^a,b   Satoh, Masataka ^a,b   Iwatsuki, Keiji ^a,c   Kaiserlian, Dominique ^b   Nicolas, Jean François ^b   Kaneko, Fumio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b University Lyon i   (France)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Allergic contact; Antigens; Dermatitis; Immunotherapy; Mice

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; B7 ANTIGEN; CD86 ANTIGEN; CYTIDINE PHOSPHATE GUANOSINE OLIGODEOXYNUCLEOTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OLIGODEOXYNUCLEOTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; FEMALE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 4143093876     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.23318.x     Document Type: Article

References (36)

1. Akiba H, Kehren J, Ducluzeau MT, et al: Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8(+) T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 168:3079-3087, 2002
2. Ban E, Dupre L, Hermann E, et al: CpG motifs induce Langerhans cell migration in vivo. Int Immunol 12:737-745, 2000
3. Bour H, Peyron E, Gaucherand M, et al: Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 25:3006-3010, 1995
4. Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G: Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 22:118-120, 2001
5. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA vaccines. Annu Rev Immunol 15:617-648, 1997
6. Dubois B, Chapat L, Goubier A, Kaiserlian D: CD4+ CD25+ T cells as key regulators of immune responses. Eur J Dermatol 13:111-116, 2003
7. Enk AH, Katz SI: Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398-1402, 1992
8. Garrigue JL, Nicolas JF, Fraginals R, Benezra C, Bour H, Schmitt D: Optimization of the mouse ear swelling test for in vivo and in vitro studies of weak contact sensitizers. Contact Dermat 30:231-237, 1994
9. Goldberg B, Urnovitz HB, Stricker RB: Beyond danger: Unmethylated CpG dinucleotides and the immunopathogenesis of disease. Immunol Lett 73:13-18, 2000
10. Grabbe S, Schwarz T: Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19:37-44, 1998
11. Halperin SA, Van Nest G, Smith B, Abtahi S, Whiley H, Eiden JJ: A phase I study of the safety and immunogenicity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine 21:2461-2467, 2003
12. Heikenwalder M, Polymenidou M, Junt T, et al: Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10:187-192, 2004
13. Hemmi H, Takeuchi O, Kawai T, et al: A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745, 2000
14. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC: Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 161:3042-3049, 1998
15. Jakob T, Walker PS, Krieg AM, von Stebut E, Udey MC, Vogel JC: Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: Implications for the augmentation of Th1 responses. Int Arch Allergy Immunol 118:457-461, 1999
16. Kaiserlian D, Etchart N: Epicutaneous and transcutaneous immunization using DNA or proteins. Eur J Dermatol 9:169-176, 1999
17. Kehren J, Desvignes C, Krasteva M, et al: Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity. J Exp Med 189:779-786, 1999
18. Kobayashi H, Horner AA, Takabayashi K, Nguyen MD, Huang E, Cinman N, Raz E: Immunostimulatory DNA pre-priming: A novel approach for prolonged Th1-biased immunity. Cell Immunol 198:69-75, 1999
19. Krasteva M, Kehren J, Horand F, et al: Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation. J Immunol 160:1181-1190, 1998
20. Krasteva M, Kehren J, Ducluzeau MT, et al: Contact dermatitis I. Pathophysiology of contact sensitivity. Eur J Dermatol 9:65-77, 1999a
21. Krasteva M, Kehren J, Sayag M, Ducluzeau MT, Dupuis M, Kanitakis J, Nicolas JF: Contact dermatitis II. Clinical aspects and diagnosis. Eur J Dermatol 9:144-159, 1999b
22. Krieg AM, Yi AK, Matson S, et al: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549, 1995
23. Lepoittevin JP, Leblond I: Hapten-peptide-T cell receptor interactions: Molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol 7:151-154, 1997
24. Ortner U, Inaba K, Koch F, Heine M, Miwa M, Schuler G, Romani N: An improved isolation method for murine migratory cutaneous dendritic cells. J Immunol Methods 193:71-79, 1996
25. Revillard JP: Innate immunity. Eur J Dermatol 12:224-227, 2002
26. Roman M, Martin-Orozco E, Goodman JS, et al: Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3:849-854, 1997
27. Sato Y, Roman M, Tighe H, et al: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354, 1996
28. Schwarz K, Storni T, Manolova V, Didierlaurent A, Sirard JC, Rothlisberger P, Bachmann MF: Role of Toll-like receptors in costimulating cytotoxic T cell responses. Eur J Immunol 33:1465-1470, 2003
29. Sun S, Kishimoto H, Sprent J: DNA as an adjuvant: Capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 187:1145-1150, 1998
30. Tascon RE, Ragno S, Lowrie DB, Colston MJ: Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells. Immunology 99:1-7, 2000
31. Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fujinami RS: Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 9:481-493, 1999
32. Vabulas RM, Pircher H, Lipford GB, Hacker H, Wagner H: CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses. J Immunol 164:2372-2378, 2000
33. Vogel JC, Udey MC: Activation of skin dendritic cells by immunostimulatory DNA. Springer Semin Immunopathol 22:45-54, 2000
34. Weiner GJ: CpG DNA in cancer immunotherapy. Curr Top Microbiol Immunol 247:157-170, 2000a
35. Weiner GJ: The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J Leukoc Biol 68:455-463, 2000b
36. Yi AK, Krieg AM: Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 161:4493-4497, 1998